Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 1 1

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Other hematologic neoplasm 1

Conditions

Locally Advanced Non-Small Cell Lung Cancer 1Leukemia, Myeloid, Acute 1Hypoxia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Atovaquone × Clear all
NCT04648033 2026-01-29

ARCADIAN

University of Oxford

Phase 1 Completed
21 enrolled 21 charts
Thoracic

Locally Advanced Non-Small Cell Lung Cancer

NCT03568994 2026-01-27

ATACC AML

Baylor College of Medicine

Phase EARLY_PHASE1 Completed
26 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02628080 2019-09-04

ATOM

University of Oxford

Phase EARLY_PHASE1 Completed
46 enrolled
Thoracic

Hypoxia, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡